Page last updated: 2024-08-16

troglitazone and ncgc00099374

troglitazone has been researched along with ncgc00099374 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gopal, K; Haque, M; Kashfi, K; Pérez, DJ; Tabatabaei Dakhili, SA; Ussher, JR; Velázquez-Martínez, CA	1

Other Studies

1 other study(ies) available for troglitazone and ncgc00099374

Article	Year
SP1-independent inhibition of FOXM1 by modified thiazolidinediones. European journal of medicinal chemistry, 2021, Jan-01, Volume: 209 Topics: Amino Acid Sequence; Antineoplastic Agents; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Protein Binding; Sp1 Transcription Factor; Thiazolidinediones; Triple Negative Breast Neoplasms; Troglitazone	2021

Article

Year

SP1-independent inhibition of FOXM1 by modified thiazolidinediones.

European journal of medicinal chemistry, 2021, Jan-01, Volume: 209

Topics: Amino Acid Sequence; Antineoplastic Agents; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Protein Binding; Sp1 Transcription Factor; Thiazolidinediones; Triple Negative Breast Neoplasms; Troglitazone

2021